Professor Paul Hutson and collaborators in the Transdisciplinary Center for Research in Psychoactive Substances study psilocybin for opioid and methamphetamine use disorders.

Professor Paul Hutson and collaborators in the Transdisciplinary Center for Research in Psychoactive Substances study psilocybin for opioid and methamphetamine use disorders.
Watch as Associate Professor Lucas Richert, of the Social and Administrative Sciences Division, and Professor Paul Hutson and Assistant Professor Cody Wenthur, both of the Pharmacy Practice and Translational Research Division, discuss where psychedelic research is today, what projects are underway here at UW–Madison, and how the role of pharmacists factors in.
Housed at the School of Pharmacy, the Transdisciplinary Center for Research in Psychoactive Substances leverages clinical and multidisciplinary expertise in emerging field of psychedelic-assisted therapy.
A new study led by School of Pharmacy researchers seeks to separate the psychedelic experience from the drugs’ therapeutic effects.
The last in a three-part series exploring how School of Pharmacy faculty are curbing the opioid epidemic, including community-driven interventions, leveraging digital games, and exploring treatment with psilocybin.
Innovative research on psychedelics is offering new hope for treating difficult psychiatric conditions where few options exist